2023 was an outstanding year for Mater Research with $13.7 million in grant funding received and 424 publications recorded.
When Monique Perry was diagnosed with aggressive triple-negative breast cancer she feared her family history was about to repeat itself.
Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.